Modification to: Monojet Prefill 0.9% Sodium Chloride Flush Syringe, Monojet Prefill Heprin Lock Flush Syringe
510(k) K032438
Active
Valid until
No expiry
FDA recalls
4 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK032438 | Date30 Jun 2004 | StatusActive |
Recalls
-
- Ongoing Z-0119-2022
Monoject 0.9% Sodium Chloride Flush Syringe Manufactured by Cardinal Health and placed into kits. Potential for the plunger to draw back after air has been expelled and reintroduce air back into the syringe.
-
- Ongoing Z-2284-2021
- Ongoing Z-2285-2021
- Ongoing Z-2286-2021
Potential for the plunger to draw back after the air has been expelled and reintroduce air back into the syringe.
-
- Terminated Z-2182-2013
- Terminated Z-2183-2013
- Terminated Z-2185-2013
- Terminated Z-2179-2013
- Terminated Z-2181-2013
- Terminated Z-2178-2013
- Terminated Z-2180-2013
- Terminated Z-2186-2013
- Terminated Z-2184-2013
Monoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
-
- Terminated Z-0568-2011
- Terminated Z-0567-2011
- Terminated Z-0566-2011
- Terminated Z-0569-2011
- Terminated Z-0564-2011
- Terminated Z-0565-2011
The heparin sodium USP used to manufacture was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.
-
- Terminated Z-1600-2008
- Terminated Z-1598-2008
- Terminated Z-1602-2008
- Terminated Z-1595-2008
- Terminated Z-1599-2008
- Terminated Z-1596-2008
Scientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant
-
- Terminated Z-1597-2008
Scientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant Tyco Healthcare, Mansfield, MA 02048
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NGT
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5200
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent